Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 23, 2019

SELL
$219.29 - $241.72 $22,806 - $25,138
-104 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$216.71 - $338.96 $14,736 - $23,049
68 Added 188.89%
104 $25,000
Q1 2018

Apr 13, 2018

BUY
$260.13 - $367.91 $9,364 - $13,244
36 New
36 $10,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Northwest Wealth Management, LLC Portfolio

Follow Northwest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Wealth Management, LLC with notifications on news.